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Pioglitazone and Simvastatin Have Complementary Anti-Inflammatory Effects
Both simvastatin and peroxisome proliferators-activated receptor (PPAR) agonistsindependently reduce certainmarkers of inflammation, but there is less known about
these effectswithcombination therapyor inpeoplewithoutdiabetes.ThePIOSTATstudy
randomized over 100 non-diabetics with coronary artery disease risk factors and elevated
C-reactive protein (CRP) to either pioglitazone, simvastatin, or the combination and
followed them for 12 weeks. Bothmonotherapies significantly reduced CRP levels;
the combination was additive, especially in patients with the metabolic syndrome.
This study suggests that patients with the metabolic syndrome may benefit from
treatment with a PPAR agonist in addition to a statin. See page 290.
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Cardiovascular Disease
and Risk
Hyperglycemia Increases Platelet Aggregation
Worthley and colleagues tested the hypothesis that elevated glucose levels lead toincreased platelet aggregation in 76 patients with acute coronary syndromes.
All patients hadbaselinemeasurements of glucose, andplatelet responsiveness; one-half
of the patients then received intravenous insulin infusions to rapidly correct glucose
levels, the other half received a standard subcutaneous insulin protocol. Platelet aggre-
gation was found to correlate directly with glucose levels and with superoxide levels.
Rapid correction of hyperglycemia restored platelet responsiveness to nitric oxide and
decreased superoxide generation.This study suggests that elevated glucose levels lead to
increased oxidative stress which inhibits the effectiveness of endothelial derived nitric
oxide to block platelet aggregation. See page 304. See figure.
Page 333
Heart Rhythm Disorders
Risk Stratification in Adults With LQTS
Sauer and colleagues report on long-term follow-up of over 800 adults withgenotype-confirmed longQTsyndrome (LQTS).The risk of future cardiac events
was higher in female subjects, those with the LQT2 genotype, those with QTc500
ms, and in those who had their first event prior to age 18 years. Beta-blockers reduced
the rate of future cardiac by 60%, but had little effect in those with the LQT3
mutation.This study provides important information that can be used to assess the risk
of future cardiac events in adults LQTS mutations. See page 329. See figure.
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Hypertrophic Cardiomyopathy
Comparing Surgical Myectomy Versus Alcohol Ablation With Cardiac MRI
Both surgical septal myectomy and percutaneous alcohol septal ablation relieve leftventricular outflow tract obstruction in patients with hypertrophic obstructive
cardiomyopathy (HOCM). Valeti and colleagues compared cardiac magnetic reso-
nance images (MRI) from nearly 50 patients who had undergone one of these
procedures. Septal myectomy results in a consistent area of myocardial resection in the
anteroseptal region and relief of the gradient. Alcohol ablation leads to a more varied
outcome, but usually results in a transmural infarction in the inferior base of the
septum. Both procedures were successful in reducing the gradient, but alcohol had
more right bundle branch block and right ventricular infarction. Magnetic resonance
imaging may help to define the optimal application of percutaneous alcohol ablation.
See page 350. See figure.
